Surging Treasury yields are challenging the Federal Reserve's approach to interest rate hikes as inflation remains above target and energy prices rise. Markets now expect multiple rate increases soon, a shift from the Fed's earlier projection of fewer hikes. Some economists warn the Fed may need five or six hikes to restore price stability, while others urge caution to avoid harming economic growth. Fed officials, including Chair Kevin Warsh, face a delicate balance between tightening policy and maintaining market confidence amid uncertain signals from bond markets.
Surging Treasury yields present challenges for Fed Chair Kevin Warsh. For readers following Financials, here is Pluang's market snapshot as of Sep 25, 2026 01:11 WIB: out of 85 Financials-sector US stocks, 39 rose and 46 fell. Notable movers include AVAT at USD 1.89 with a -13.50% change, LU at USD 1.38 up 13.11%, and APO at USD 120.04 down 3.47%.
Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...
Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...
Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...
Western Union faces multiple analyst downgrades with price targets cut to as low as $6.00, reflecting concerns over its profitability and competitive pressures from fintech rivals. The stock has fallen over 15% in the past month, trading near $6.00, ...
Citigroup lowered ACADIA Pharmaceuticals' price target from $40 to $33 after its Alzheimer's drug remlifanserin missed the primary goal in a mid-stage trial, causing a 10.5% stock drop. Despite this, Citigroup kept a "Buy" rating, citing promising se...
